People with HIV at greater risk for developing heart disease, new research suggests

HIV puts individuals at higher risk for developing several chronic diseases, one of them being coronary artery disease (CAD). Medical professionals know this but haven’t been able to pinpoint the underlying reasons that contribute to the development of the disease. But new research delves into why and how CAD can develop.

Hossein Bahrami, MD, PhD, an assistant professor of cardiovascular medicine at the Keck School of Medicine at the University of Southern California, was the lead author on the study. He worked with scientists from Johns Hopkins University and five other institutions on the study, which was published June 27 in the Journal of the American Heart Association.

Bahrami and his team studied 923 men, 575 of whom had HIV, from the Multicenter AIDS Cohort Study. They used computed tomography angiography technology to look for signs of subclinical CAD, things like narrowed arteries and high amounts of plaque.

Participates were also examined for the presence of seven inflammatory biomarkers.

The researchers found that men with HIV had significantly higher levelers of interleukin-6, intercellular adhesions molecule-1, C-reactive protein and soluble-tumor necrosis factor-x receptor, all inflammatory biomarkers. Additionally, they found a higher prevalence of plaque in men with HIV.

There was also a strong and independent association between the presence of the inflammatory biomarkers and subclinical CAD picked up by the CT scan, suggesting that persistent inflammation may increase one’s risk of developing heart disease.

“Higher inflammatory marker levels are associated with greater prevalence of coronary stenosis in HIV-positive men,” the authors wrote in the study. “Our findings underscore the need for further study to elucidate the relationships of inflammatory pathways with coronary artery disease in HIV-positive individuals.”

The study was funded by the National Institutes of Health.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup